Funding profile · Pediatric telemedicine
Blueberry Pediatrics
A Y Combinator company that has raised money since 2018 without filing a single Form D. Three commercial trackers put the total at $9.45M, $12.11M and $15.5M. Only two round amounts appear anywhere on the public record.
0Form D notices on file with the SEC under any Blueberry name
$15.5MTotal raised, PitchBook estimate (accessed Sep 2026)
$12.11MTotal raised across 7 rounds, CB Insights estimate
$9.45MTotal raised across 2 rounds, Tracxn estimate
Data as of September 22, 2026. Company-reported and tracker-reported figures are labeled.
Rounds at a glance
| When | Round | Amount | Investors | Source |
|---|---|---|---|---|
| Winter 2018 | Y Combinator batch | $125K (PitchBook, dated Jul 2018) | Y Combinator | Tracker |
| Mar to Apr 2019 | Seed | $2.0M · raised to date $2.12M | Not named | Tracker |
| Apr 23, 2020 | Seed, second | Not disclosed | One New York venture firm, unnamed | Tracker |
| Dec 30, 2020 | Seed, third | Not disclosed | Not named | Tracker |
| Jan 12 to 14, 2022 | Seed, fourth | Not disclosed | WVV Capital wrote publicly about its investment in Oct 2022; MS&AD Ventures lists the company in its portfolio | Tracker and investor post |
| Mar 1, 2023 | Series A | Not disclosed · Tracxn puts a Series A at $9.3M | MS&AD Ventures named by CB Insights | Tracker |
| 2025 | Accelerator or fellowship | Not disclosed | WBL Fellows Program listed among investors | Tracker |
What the filings show
SEC EDGAR · no Form D on file · searched Sep 23, 2026
- Company search
- Seven EDGAR registrants match the name Blueberry. None is the pediatric company: ranches, a realty trust, an entertainment company, two funds.
- Full text search
- One hit for the phrase Blueberry Pediatrics across all EDGAR filings, an exhibit filed by an unrelated issuer in April 2021. No hits for Blueberry Medical.
- Form D notices
- None, under any spelling, at any date
- Named investors on the record
- Y Combinator, Divide by Zero, WVV Capital, MS&AD Ventures, C Holdings, WBL Fellows Program
- Investor counts
- Tracxn 16, CB Insights 27, PitchBook 33
Reading the filings
- The absence of a Form D is normal, not evasive.An issuer selling under Section 4(a)(2) rather than Regulation D files no Form D at all. Priced institutional rounds usually do file, so seven tracker-reported rounds with zero notices points to safes and notes throughout. Either way, the SEC record carries no dollar figure for this company.
- The trackers disagree by more than the smallest of them.PitchBook says $15.5M, CB Insights $12.11M, Tracxn $9.45M. The spread between the high and low figures is $6.05M, which is 64% of Tracxn’s total. They also disagree on round count, 7 against 2, and on investor count, 33 against 16. None of the three is a filing.
- Only two amounts exist anywhere on the public record.A $125K accelerator cheque in 2018 and a $2.0M seed in 2019, with raised to date reported as $2.12M at that point. Every round after April 2019, including the Series A, is undisclosed. The $9.3M Series A figure comes from a single tracker and is unconfirmed elsewhere.
- The company stopped talking about capital and started talking about revenue.The 2026 Inc. 5000 ranking at No. 840 is based on revenue growth from 2022 to 2025 and requires at least $2 million of 2025 revenue to qualify. That is the only revenue-linked figure with an external gatekeeper behind it. A separate tracker estimate of $5M ARR for 2024 is a model output, not a disclosure.
- The hiring pattern is what a company does before a large raise or a sale.In August 2025 a former MDLive chief executive took the CEO seat and a former Teladoc chief operating officer became executive chairman. In 2026 the company added a CFO whose stated record includes due diligence on a private equity exit. Those are exit-adjacent hires, not product hires.
- Revenue risk has moved onto the balance sheet.The Aetna Better Health of Illinois announcement says Blueberry “guarantees its fees against emergency department costs” and that “If the program’s savings do not exceed its fees, Blueberry will reimburse Aetna Better Health of Illinois.” That converts a subscription into a performance obligation. No reserve, contract value or claw-back figure has been published.
Commercial signals
| Signal | Detail | Source type |
|---|---|---|
| Payer contracts | Five named Medicaid plans across Illinois, Nevada and Texas between Mar 2024 and Jun 2026. Only Meridian published an enrolment figure, more than 2,400 members. | Plan-stated |
| Employer channel | Carrot added Blueberry as a parenting benefit add-on in Feb 2026 for children under 12, plan sponsor paid. Carrot reports more than 1,200 customers. | Independent |
| Consumer pricing | $216 per year, or $18 per month, plus a one-time kit fee. Launch pricing in 2021 was $18 per month plus $100 for the kit. | Company-stated |
| Savings claim | Stated as 40%, as 50% and as 95% in three different company documents. No underlying analysis published. | Claims differ |
| Regulatory exposure | No FDA device clearance or registration under the Blueberry name. The kit uses off the shelf devices, so the regulatory risk sits with the clinical practice, not the hardware. | Public record |
| Clinical evidence | No registered trial and no peer-reviewed publication of Blueberry outcomes. Published work on direct-to-consumer pediatric telemedicine reports higher antibiotic prescribing than primary care. | Not found |
What to watch
- A first Form D. It would be due within 15 days of the first sale of any Regulation D round, and would be the first hard number since 2019.
- Whether any health plan publishes its own claims analysis of the program rather than restating the company figure.
- Renewal or non-renewal of the Illinois, Nevada and Texas contracts, which is the real test of the fee guarantee.
- An acquisition. The 2025 and 2026 hires came from MDLive, Teladoc and Allscripts.
The Blueberry Pediatrics story on Healthcare DiscoveryHealthcare Discovery
Related companies
Sources
- Public recordSEC EDGAR full text search and company search for Blueberry entities, no Form D found
- Public recordNPPES NPI Registry, Blueberry Medical PA and Blueberry Medical of New Jersey PA
- Public recordopenFDA device classification, 510(k) and registration searches for Blueberry
- TrackerBlueberry Pediatrics company profile, funding and cap table
- TrackerBlueberry Pediatrics financials, rounds and investor list
- TrackerBlueberry Pediatrics funding rounds and investors
- InvestorWVV’s Investment in Blueberry Pediatrics
- IndependentCarrot teams up with Blueberry Pediatrics for on-demand telehealth access
- PartnerAetna Better Health of Illinois and Blueberry Pediatrics Team Up to Expand Pediatric Care Access in Cook County
- PlanMeridian Health Plan of Illinois Offers Telehealth for its YouthCare Members
- CompanyBlueberry Pediatrics Named No. 840 on the 2026 Inc. 5000 List
- CompanyBlueberry Pediatrics Unveils Powerhouse Leadership Team, and CFO appointment release
Compiled from SEC, CMS and FDA public records, commercial funding trackers and published reports as of September 22, 2026. No Form D notice has been filed for this company, so no Regulation D offering amount exists on the public record; tracker totals are estimates, not filings. Healthcare Venture Capital Fund holds no position in Blueberry Pediatrics. This page is not an offer to sell or a recommendation to buy any security.